Individualizing follow-up for patients with early-stage melanoma

Journal of Clinical Oncology

Volumn 29, Issue 35, 2011, Pages 4606-4608

  Sondak, Vernon K ^a   Leachman, Sancy A ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; EARLY CANCER; EDITORIAL; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL SPECIALIST; MELANOMA; METASTASIS; PATIENT CARE; PRIORITY JOURNAL; SKIN BIOPSY; XERODERMA PIGMENTOSUM;

AFTERCARE; HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 83355169745     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.6681     Document Type: Editorial

References (5)

1. Resneck JS Jr, Tierney EP, Kimball AB: Challenges facing academic dermatology: Survey data on the faculty workforce. J Am Acad Dermatol 54:211-216, 2006 (Pubitemid 43144388)
2. Kimball AB, Resneck JS Jr: The US dermatology workforce: A specialty remains in shortage. J Am Acad Dermatol 59:741-745, 2008
3. Turner RM, Bell KJ, Morton RL, et al: Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. J Clin Oncol 29:4641-4646, 2011
4. Siegel R, Ward E, Brawley O, et al: Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212-236, 2011
5. Romano E, Scordo M, Dusza SW, et al: Site and timing of first relapse in stage III melanoma patients: Implications for follow-up guidelines. J Clin Oncol 28:3042-3047, 2010